Results

Total Results: 153 records

Showing results for "central nervous".

41. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - nervous system; GM1 = monosialotetrahexosylganglioside; HSCT = hematopoietic stem- cell transplantation … nervous system embryonal tumors, and germ cell tumors. … • For single HSCT versus conventional therapy for central nervous system embryonal tumors, high-risk … NERVOUS SYSTEM TUMORS Sands SA, Oberg JA, Gardner SL, Whiteley J. … HIGH RISK CNS TUMORS Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors;

42. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - This drug combination acts on the central nervous system as an appetite suppressant. … Phentermine is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite … This drug combination acts on the central nervous system as an appetite suppressant. 1 Phentermine … is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant

43. Binge-Eating Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
    December 01, 2015 - Pharmacological Central nervous system stimulants Treatment with a class of medications generally used … Topiramate was associated with a significantly higher number of events involving sympathetic nervous … higher likelihood of insomnia and headache (high strength of evidence), as well as greater GI upset, central … nervous system arousal, and decreased appetite (moderate strength of evidence). … Symptoms of sympathetic nervous system arousal were more common among patients who received topiramate

44. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol

45. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
    November 01, 2021 - Desoxyn OR "Alpha agonist" OR "Attention Deficit Disorder with Hyperactivity/drug therapy"[Majr] OR "Central … Nervous System Stimulants"[MeSH] OR "Methylphenidate"[MeSH] OR "Dexmethylphenidate"[MeSH] OR "Dextroamphetamine … Nervous System Stimulants" [Pharmacological Action] OR "Adrenergic alpha-2 Receptor Agonists" [Pharmacological … Systematic Review Protocol 31 Inhibitors" [Pharmacological Action] OR "Central … Nervous System Stimulants"[tiab] OR "psychostimulant"[tiab] OR "Methylphenidate"[tiab] OR "Methylphenidate

46. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - pharmacologic antidepressant monotherapy, placebo, or nonpharmacologic therapy Abbreviations: CNS=central … nervous system; ECG=electrocardiogram; ER=emergency room; KQ=Key Question; MDD= major depressive disorder … selective serotonin reuptake inhibitor Data Sources Data sources were MEDLINE®, Embase®, Cochrane Central

47. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
    November 01, 2010 - nonhematologic (or solid tumors) which include primary brain tumors, and those derived from the peripheral nervous … incidences) Germ cell tumor (GCT) Relapsed Auto (allo if fail auto and in selected incidences) Central … Nervous System Embryonal Tumors Relapsed or residual Auto Source: www.effectivehealthcare.ahrq.gov … Tandem Auto Auto Single Autologous Germ cell tumor (GCT) Relapsed Tandem Auto Auto Single Autologous Central … Nervous System Embryonal Tumors Initial therapy Auto Tandem Auto Auto Conventional Chemotherapy

48. ADHD-Update-protocol-160818 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
    August 18, 2016 - tiab] #3 #1 AND #2 #4 "Attention Deficit Disorder with Hyperactivity/drug therapy"[Majr] OR "Central … Nervous System Stimulants"[MeSH] OR "Methylphenidate"[MeSH] OR "Dexmethylphenidate"[MeSH] OR "Dextroamphetamine … Nervous System Stimulants" [Pharmacological Action] OR "Adrenergic alpha-2 Receptor Agonists" [Pharmacological … Inhibitors" [Pharmacological Action] OR "Monoamine Oxidase Inhibitors" [Pharmacological Action] OR "Central … Nervous System Stimulants"[tiab] OR “psychostimulant”[tiab] OR “Methylphenidate”[tiab] OR "Methylphenidate

49. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_surveillance.pdf
    January 30, 2013 - ) In-Process & Other Non- Indexed Citations and Ovid MEDLINE(R), Embase, and EBM Reviews - Cochrane Central … .11,22,23 In a case series of 51 women, one participant had dislodgment of catheter (2 percent, exact central … CI: 0.5%, 10%) and there was one pump that malfunctioned (2 percent, exact central CI: 0.5%, 10%) … .11,22,23 In a case series of 51 women, one participant had dislodgment of catheter (2 percent, exact central … CI: 0.5%, 10%) and there was one pump that malfunctioned (2 percent, exact central CI: 0.5%, 10%).22

50. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
    January 30, 2013 - ) In-Process & Other Non- Indexed Citations and Ovid MEDLINE(R), Embase, and EBM Reviews - Cochrane Central … .11,22,23 In a case series of 51 women, one participant had dislodgment of catheter (2 percent, exact central … CI: 0.5%, 10%) and there was one pump that malfunctioned (2 percent, exact central CI: 0.5%, 10%) … .11,22,23 In a case series of 51 women, one participant had dislodgment of catheter (2 percent, exact central … CI: 0.5%, 10%) and there was one pump that malfunctioned (2 percent, exact central CI: 0.5%, 10%).22

51. Emergency Medical Service/911 Workforce Mental or Behaviorial Health Issues (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
    February 01, 2022 - The Journal of nervous and mental disease. 2008 Dec;196(12):912-8. doi: 10.1097/NMD.0b013e31818ec95d … The Journal of nervous and mental disease. 2007 Oct;195(10):861-5. doi: 10.1097/NMD.0b013e3181568612 … Alcohol use among firefighters in the Central United States. … The Journal of nervous and mental disease. 2015 Mar;203(3):205-9. … The Journal of nervous and mental disease. 2017 Feb;205(2):154-60. doi: 10.1097/nmd.0000000000000563

52. Comparative Effectiveness of Preventive Pharmacological Treatments for Migraine | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/migraine-prevention/research-protocol

53. Acute Migraine Treatment in Emergency Settings | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/migraine-emergency/research-protocol

54. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
    July 18, 2011 - the Systematic Review Migraine is a neurovascular disorder characterized by dysfunction of the central … and peripheral nervous systems and intracranial vasculature. 1 Acute exacerbations of episodic and … MEDLINE, as this is the most comprehensive database, and will be replicated in EMBASE, the Cochrane Central … Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR), the

55. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - This drug combination acts in the central nervous system as an appetite suppressant. … This drug combination acts on the central nervous system as an appetite suppressant. 15 Phentermine … is a central norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant

56. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
    February 07, 2018 - Polypharmacy • Concurrent use of other medications with CNS activity (KQ 1) Abbreviations: CNS=central … nervous system; KQ=key question; MDD= major depressive disorder; SIADH=syndrome of inappropriate antidiuretic … Ovid MEDLINE, Ovid MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, PsychInfo, and Cochrane Central

57. Noninvasive, Nonpharmacological Treatment for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
    September 20, 2017 - relationships with family; it is the leading cause of disability and is often refractory to treatment.3,4 Nervous … distinct disease entity.2 This multifaceted disease is influenced by multiple factors (e.g., genetic, central … nervous system, psychological, and environmental factors), with complex interactions, making assessment … Literature Databases: Ovid MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database … 36 34 or 35 37 31 or 36 Database: EBM Reviews - Cochrane Central

58. The Role of Immunotherapy and the Management of Asthma: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
    September 14, 2016 - We will search PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). … The effects of blocking central nervous system H1 receptors are not as well understood.

59. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - Sources: We will search the research databases PubMed, EMBASE, CINAHL, Cochrane Central Register of … Controlled Trials (CENTRAL), Web of Science, Scopus, and TOXLINE to identify controlled studies evaluating … Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic … Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review … connective tissue disorders • Neoplasms benign, malignant and unspecified (incl. cysts and polyps) • Nervous

60. Fecal-Incontinence Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
    November 30, 2014 - Neurological causes of FI include damage to the nervous system or advanced cognitive impairment. … Relevant bibliographic databases for this topic include Ovid MEDLINE®, Embase, CINAHL, the Cochrane Central … Register of Controlled Trials (CENTRAL), Ovid Physiotherapy Evidence Database (PEDro), and Allied and … Management of faecal incontinence and constipation in adults with central neurological diseases. … Cochrane Central Register of Controlled Trials FDA Food and Drug Administration FI Fecal Incontinence